Drug quality has become a bigger regulatory priority in India as authorities intensify inspections to strengthen manufacturing standards
Osteoarthritis treatment could see a new stem cell-based approach after Bengaluru-based Stempeutics Research secured a US patent.
Drug Resistance is becoming harder to manage as bacteria stop responding to commonly used antibiotics. Wockhardt is now targeting this challenge through a new scientific learning platform.
Drug approvals, MedTech innovation, and pharma legal battles are driving major healthcare developments across global and Indian markets
Indian pharma is gaining a stronger foothold in Nigeria as bilateral economic ties expand and companies deepen their presence across Africa
Gujarat is drawing fresh pharma investment worth INR 2,500-3,000 crore. The money is going into new drug manufacturing facilities across the state. The investment follows approvals for 59 new allopathic medicine plants during FY2025-26.
Gland Pharma reported a strong Q1 profit. The company posted revenue of INR 1,800.27 crore in Q1 FY27. Its net profit rose 47.1% year over year to INR 316.95 crore.
India’s TB screening drive has uncovered a major number of cases, highlighting the scale of hidden tuberculosis. More than 2.2 crore people were screened during the 100-day campaign, with over 7 lakh TB cases detected. Union Health Minister...
Pharma exports, drug regulation, and rare disease therapies are signaling a broader shift across the pharmaceutical sector
Fertility drug regulation has come under scrutiny after the Central Drugs Standard Control Organization flagged the unauthorized manufacture
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
